Market Summary
Artificial Lung Market Overview
As per MRFR analysis, the Artificial Lung Market Size was estimated at 1.44 (USD Billion) in 2024. The Artificial Lung Market Industry is expected to grow from 1.56 (USD Billion) in 2025 to 3.17 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 8.18% during the forecast period (2025 - 2034).
Key Artificial Lung Market Trends Highlighted
The Global Artificial Lung Market is on the rise, supported mainly by the increasing number of chronic respiratory disease patients, such as Chronic Obstructive Pulmonary Disease and pulmonary fibrosis, as well as their procedures that warrant lung support. There are also newer advancements in lung devices that are changing the functionalities of aided lungs to suit the patients. The presence of better-advanced lung disease care also draws from the need for an aging society that suffers diseases in greater quantities. Advancements aid all these.
The market for artificial lungs has also been boosted by the new designs and materials that have been developed for the lungs. More recently, there has been an increasing emphasis on clinically portable devices that can be utilized in the home environment and not just on hospital grounds. There is a critical need for partnerships between medical device manufacturers, research organizations or institutions, and healthcare providers in order to shorten the time to market and enhance product features. While the area on the personalization of treatment has been emphasized, opportunities for new lung markets are attracted as the solutions are targeted at patient requirements. As positive outcomes are witnessed in patients and the necessary healthcare awareness spreads across the relevant professionals, the market to which this technology is aimed is steadily increasing.
Pazienti e medici si stanno dimostrando sempre piu’ propensi a impiegare tecniche mini invasive per l’Oxigeno Terapia Meccanica. Al contempo, l’incontro della telemedicina e della considerazione del machine learning nel trattamento respiratorio favoriranno la personalizzazione della terapia sul paziente. A tale evoluzione non solo fa riscontro, investimento in dispositivi assistivi artificiali polmonari, ma anche l’imminente possibilita’ di utilizzo della farmaceutica tradizionale, al fine di ottimizzare i cardiocircolatori.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Artificial Lung Market Drivers
Increasing Prevalence of Chronic Respiratory Diseases
The increasing prevalence of chronic respiratory diseases, such as chronic obstructive pulmonary disease (COPD) and pulmonary fibrosis, is a significant driver for the Global Artificial Lung Market Industry. As these conditions become more prevalent due to factors such as smoking, pollution, and an aging population, there is a growing need for effective respiratory support and management solutions. Artificial lungs can play a crucial role in sustaining patients' lives when natural lung function is severely compromised.With projections indicating significant growth in affected populations, the demand for artificial lung devices is expected to rise substantially. This trend is supported by ongoing advancements in medical technology, enhancing the efficacy and safety of artificial lung devices. Furthermore, healthcare systems are increasingly recognizing the importance of addressing respiratory illnesses promptly to improve patient outcomes and reduce healthcare costs associated with prolonged treatments and hospitalizations.The Global Artificial Lung Market Industry is poised to benefit from this growing awareness and the consequential increase in product adoption, and innovation focused on respiratory support systems.
Technological Advancements in Artificial Lung Devices
Technological advancements in artificial lung devices are a critical driver for the growth of the Global Artificial Lung Market Industry. Innovations in materials, design, and manufacturing processes are leading to the development of more efficient, durable, and user-friendly artificial lungs. Enhanced biocompatibility of materials reduces the risk of complications, while innovations in miniaturization and portability enable easier integration into various healthcare settings.These advancements are instrumental in improving the overall performance of artificial lungs, which increases their adoption by medical facilities and patients alike. Furthermore, continued investment in research and development is fostering groundbreaking solutions, increasing the appeal of artificial lung technology across the globe.
Government Initiatives and Funding for Respiratory Health
Government initiatives and funding aimed at improving respiratory health drive growth in the Global Artificial Lung Market Industry. Many governments worldwide are recognizing the burden of respiratory diseases on public health and are implementing programs to fund research, improve healthcare infrastructure, and facilitate access to treatment. Such initiatives often include grants for technological innovation in medical devices, including artificial lungs, encouraging the development of cutting-edge solutions.Additionally, these governmental efforts often raise awareness about respiratory health, leading to early diagnosis and increased demand for artificial lung devices as part of comprehensive patient care plans.
Artificial Lung Market Segment Insights:
Artificial Lung Market Type Insights
The Global Artificial Lung Market showcases a diverse landscape, classified into various types, notably Extracorporeal Membrane Oxygenation, Ventilator Support Systems, and Implantable Artificial Lungs. In 2023, the market generated a total revenue of 1.23 USD Billion, indicating the growing need for advanced respiratory support systems. The Extracorporeal Membrane Oxygenation (ECMO) segment emerged as a significant contributor, with a value of 0.6 USD Billion in 2023 and projected to grow to 1.2 USD Billion by 2032. The prominence of ECMO can be attributed to its critical role in providing cardiac and respiratory support for patients suffering from severe respiratory failure, particularly in intensive care settings.Ventilator Support Systems, another key segment, garnered a value of 0.5 USD Billion in 2023, with expectations of reaching 0.9 USD Billion by 2032.
The increasing incidence of chronic respiratory diseases and the need for efficient patient management have positioned this segment as a major player in the market. Furthermore, Implantable Artificial Lungs, although comparatively smaller, valued at 0.13 USD Billion in 2023 and anticipated to rise to 0.4 USD Billion by 2032, are gaining traction due to advancements in biocompatible materials and integrated technologies, offering promising alternatives for long-term respiratory support.The overall market segmentation highlights the rising demand for innovative artificial lung solutions driven by factors such as an aging population, increasing prevalence of respiratory illnesses, and the necessity for efficient emergency and critical care management. However, challenges such as high costs associated with these technologies and the complexity of treatments may impact market growth. Emerging opportunities lie in technological advancements and the potential for expanding applications of artificial lung systems in both clinical and home settings, paving the way for enhanced patient management solutions.As the Global Artificial Lung Market evolves, the insights from each type segment not only reflect the current landscape but also set a framework for innovative growth pathways in the region and beyond.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Artificial Lung Market Application Insights
The Global Artificial Lung Market, valued at 1.23 billion USD in 2023, is experiencing significant growth driven by vital applications in treating various respiratory issues. The market showcases a diverse segmentation that addresses critical needs such as respiratory failure, lung transplantation, and cardiac support. Respiratory failure has become a prominent area, as it necessitates advanced solutions for patients requiring prolonged oxygen support. Lung transplantation remains a significant application due to the increasing demand for donor organs and the advanced technologies emerging in artificial lung systems.The cardiac support category plays a crucial role, providing essential assistance for patients with severe heart conditions, allowing for improved recovery times and better quality of life. As healthcare technology continues to advance, the Global Artificial Lung Market data shows that these applications are positioned to dominate market growth, driven by increasing patient populations, advancements in medical technologies, and a heightened awareness of treatment options available. Overall, the Global Artificial Lung Market statistics emphasize how these applications collectively support overall market expansion within this innovative industry.
Artificial Lung Market End-Use Insights
The Global Artificial Lung Market in 2023 was valued at approximately 1.23 billion USD, driven by increasing demand for lung support systems across various end-use settings. Hospitals represent a critical segment in the market, as they are central to managing severe pulmonary diseases and respiratory failure cases, providing necessary advanced care. Home care is also gaining traction, offering more personalized patient management and convenience, which is essential for chronic lung conditions. Specialized clinics are important as well, addressing unique patient needs and contributing to innovation and access within the market.The Global Artificial Lung Market data reflects a diversification in end-use applications, indicating that the healthcare sector is adapting to a rise in respiratory conditions and an aging population, which in turn fuels market growth. Market trends highlight a shift towards more patient-centric care solutions and technological advancements, but the industry also faces challenges like regulatory hurdles and high costs. Nevertheless, significant opportunities exist for growth, especially in improving accessibility and affordability in home care settings, where demand is expected to rise steadily in the coming years.The Global Artificial Lung Market statistics exemplify the necessity for targeted strategies to cater to each end-use category effectively.
Artificial Lung Market Product Configuration Insights
The Global Artificial Lung Market, valued at 1.23 billion USD in 2023, showcases a diverse Product Configuration segment that includes Portable Systems, Stationary Systems, and Wearable Systems. The growth of the market is evident, with projections of reaching 2.5 billion USD by 2032, reflecting a strong market orientation towards advanced respiratory solutions. Portable Systems have gained prominence due to their convenience and mobility, catering to patients who require lung support on-the-go. Stationary Systems continue to dominate the market as they offer robust support for patients with severe respiratory conditions who need constant monitoring and care.Meanwhile, Wearable Systems are emerging as a significant trend, driven by technological innovations that allow for easier integration into daily life, enhancing patient comfort and adherence to treatment. Overall, these configurations are critical in fulfilling the diverse needs of patients optimizing treatment outcomes, and are supported by trends emphasizing personalized healthcare solutions. The Global Artificial Lung Market data illustrates a clear trend towards these system configurations, indicating a growing acceptance of advanced respiratory management options in clinical settings.
Artificial Lung Market Regional Insights
The Global Artificial Lung Market is experiencing significant growth across various regions, with North America leading the way. It was valued at 0.5 USD Billion in 2023 and is projected to reach 1.02 USD Billion by 2032, indicating its majority holding in overall market revenue. Europe follows with a valuation of 0.3 USD Billion in 2023, expected to grow to 0.64 USD Billion, showcasing its significant role in the market dynamics. The APAC region is valued at 0.25 USD Billion in 2023 and is projected to reach 0.52 USD Billion, highlighting emerging opportunities in this area.South America and the MEA regions contribute with valuations of 0.1 USD Billion and 0.08 USD Billion in 2023, respectively, reaching 0.22 USD Billion and 0.2 USD Billion by 2032. The challenges in these regions, including regulatory hurdles and market access, are overshadowed by growth drivers such as advancements in technology and an increasing prevalence of respiratory diseases. The Global Artificial Lung Market segmentation reflects not only geographical expansion but also the growing need for innovative solutions in artificial lung technology, indicating a promising landscape for future investments and developments.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Artificial Lung Market Key Players and Competitive Insights:
The Global Artificial Lung Market has witnessed significant developments and expansions as healthcare technology continues to advance, and the need for efficient respiratory support increases globally. Competitive insights in this market reveal a landscape where innovation is key, with manufacturers focusing on enhancing product efficacy, safety, and integration capabilities with existing healthcare systems. The interplay of various market dynamics, including regulatory frameworks, technological advancements, and competitive strategies, influences the market's growth trajectory. Companies are engaged in strategic collaborations, research and development, and mergers and acquisitions, aiming to enhance their product portfolios and establish a stronger foothold in the market. As the market evolves, the emphasis on patient-centric solutions and personalized healthcare continues to rise, prompting firms to develop advanced artificial lung technologies that cater to different patient needs.Abbott Laboratories has established itself as a significant player in the Global Artificial Lung Market. The company is recognized for its robust product development pipeline and commitment to innovation, which is key to staying competitive. Leveraging advanced research and development capabilities, Abbott Laboratories aims to create artificial lung solutions that not only meet market demands but also adhere to the rigorous safety and regulatory standards required in the healthcare sector. The company's strengths lie in its strong brand recognition, capabilities in optimizing manufacturing processes, and a dedicated focus on addressing specific respiratory challenges faced by patients. This strategic positioning allows Abbott Laboratories to maintain a solid market presence and foster long-term relationships with healthcare providers and institutions focusing on respiratory care.Asahi Kasei Corporation is another prominent entity in the Global Artificial Lung Market, distinguished by its innovative approach and technological prowess in developing artificial lung systems. The company utilizes advanced polymer technology and materials science to design products that offer enhanced performance and biocompatibility. Asahi Kasei's strengths include its ability to leverage cutting-edge research, ensuring that its artificial lung devices meet evolving healthcare needs and regulatory requirements. This dedication to innovation enables Asahi Kasei Corporation to not only compete effectively within the market but also to establish partnerships with healthcare professionals and research institutions. The company's commitment to providing high-quality and efficient respiratory support solutions further solidifies its position as a leading competitor in this dynamic market.
Key Companies in the Artificial Lung Market Include:
- Abbott Laboratories
- Asahi Kasei Corporation
- Xenios AG
- LivaNova
- Baxter International
- Nipro Corporation
- Getinge AB
- Air Products and Chemicals
- Sangart
- Tandem Diabetes Care
- Cleveland Clinic
- C3S
- Terumo Corporation
- Fresenius Medical Care
Artificial Lung Market Industry Developments
The Global Artificial Lung Market has recently witnessed significant developments driven by advancements in medical technology and increasing demand for alternative respiratory solutions. Companies such as Abbott Laboratories and Medtronic are continually innovating to improve the efficiency and safety of artificial lung systems, creating a ripple effect on market growth. Additionally, Asahi Kasei Corporation and Getinge AB are exploring collaborations that aim to enhance product offerings for patients with advanced lung diseases. The market is also witnessing an uptick in mergers and acquisitions, with LivaNova and Fresenius Medical Care looking to expand their market share, leveraging synergies for improved operational efficiencies and enhanced product portfolios. Furthermore, Nipro Corporation and Baxter International are reportedly investing in R&D to accelerate the development of next-generation artificial lungs, catering to the increasing global healthcare needs. The overall market valuation is expected to rise significantly as stakeholders are keen to capitalize on these innovations and strategic partnerships, reflecting a favorable shift in the competitive landscape. Overall, the landscape remains dynamic, with strong investor interest and active corporate strategies defining the current state of the artificial lung market.
Artificial Lung Market Segmentation Insights
Artificial Lung Market Type Outlook
- Extracorporeal Membrane Oxygenation
- Ventilator Support Systems
- Implantable Artificial Lungs
Artificial Lung Market Application Outlook
- Respiratory Failure
- Lung Transplantation
- Cardiac Support
Artificial Lung Market End-Use Outlook
- Hospitals
- Home Care
- Specialized Clinics
Artificial Lung Market Product Configuration Outlook
- Portable Systems
- Stationary Systems
- Wearable Systems
Artificial Lung Market Regional Outlook
- North America
- Europe
- South America
- Asia-Pacific
- Middle East and Africa
Market Size & Forecast
| Report Attribute/Metric | Details |
|
Market Size 2024 |
1.44 (USD Billion) |
|
Market Size 2025 |
1.56 (USD Billion) |
|
Market Size 2034 |
3.17 (USD Billion) |
|
Compound Annual Growth Rate (CAGR) |
8.18 % (2025 - 2034) |
|
Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
|
Base Year |
2024 |
|
Market Forecast Period |
2025 - 2034 |
|
Historical Data |
2020 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Abbott Laboratories, Asahi Kasei Corporation, Xenios AG, LivaNova, Baxter International, Nipro Corporation, Getinge AB, Air Products and Chemicals, Sangart, Tandem Diabetes Care, Cleveland Clinic, C3S, Terumo Corporation, Fresenius Medical Care, Medtronic |
| Segments Covered | Type, Application, End Use, Product Configuration, Regional |
| Key Market Opportunities | Technological advancements in design, Rising prevalence of respiratory diseases, Increased demand for organ substitutes, Growth in the home healthcare market, Strategic partnerships and collaborations |
| Key Market Dynamics | Increasing prevalence of respiratory diseases, Technological advancements in devices, Growing elderly population, Rising healthcare expenditure, Demand for minimally invasive procedures |
| Countries Covered | North America, Europe, APAC, South America, MEA |
Major Players
Artificial Lung Market Market Segmentation
-
Artificial Lung Market By Type (USD Billion, 2019-2032)
-
Extracorporeal Membrane Oxygenation
-
Ventilator Support Systems
-
Implantable Artificial Lungs
-
-
Artificial Lung Market By Application (USD Billion, 2019-2032)
-
Respiratory Failure
-
Lung Transplantation
-
Cardiac Support
-
-
Artificial Lung Market By End Use (USD Billion, 2019-2032)
-
Hospitals
-
Home Care
-
Specialized Clinics
-
-
Artificial Lung Market By Product Configuration (USD Billion, 2019-2032)
-
Portable Systems
-
Stationary Systems
-
Wearable Systems
-
-
Artificial Lung Market By Regional (USD Billion, 2019-2032)
-
North America
-
Europe
-
South America
-
Asia Pacific
-
Middle East and Africa
-
Artificial Lung Market Regional Outlook (USD Billion, 2019-2032)
-
North America Outlook (USD Billion, 2019-2032)
-
North America Artificial Lung Market by Type
-
Extracorporeal Membrane Oxygenation
-
Ventilator Support Systems
-
Implantable Artificial Lungs
-
-
North America Artificial Lung Market by Application Type
-
Respiratory Failure
-
Lung Transplantation
-
Cardiac Support
-
-
North America Artificial Lung Market by End Use Type
-
Hospitals
-
Home Care
-
Specialized Clinics
-
-
North America Artificial Lung Market by Product Configuration Type
-
Portable Systems
-
Stationary Systems
-
Wearable Systems
-
-
North America Artificial Lung Market by Regional Type
-
US
-
Canada
-
-
US Outlook (USD Billion, 2019-2032)
-
US Artificial Lung Market by Type
-
Extracorporeal Membrane Oxygenation
-
Ventilator Support Systems
-
Implantable Artificial Lungs
-
-
US Artificial Lung Market by Application Type
-
Respiratory Failure
-
Lung Transplantation
-
Cardiac Support
-
-
US Artificial Lung Market by End Use Type
-
Hospitals
-
Home Care
-
Specialized Clinics
-
-
US Artificial Lung Market by Product Configuration Type
-
Portable Systems
-
Stationary Systems
-
Wearable Systems
-
-
CANADA Outlook (USD Billion, 2019-2032)
-
CANADA Artificial Lung Market by Type
-
Extracorporeal Membrane Oxygenation
-
Ventilator Support Systems
-
Implantable Artificial Lungs
-
-
CANADA Artificial Lung Market by Application Type
-
Respiratory Failure
-
Lung Transplantation
-
Cardiac Support
-
-
CANADA Artificial Lung Market by End Use Type
-
Hospitals
-
Home Care
-
Specialized Clinics
-
-
CANADA Artificial Lung Market by Product Configuration Type
-
Portable Systems
-
Stationary Systems
-
Wearable Systems
-
-
-
Europe Outlook (USD Billion, 2019-2032)
-
Europe Artificial Lung Market by Type
-
Extracorporeal Membrane Oxygenation
-
Ventilator Support Systems
-
Implantable Artificial Lungs
-
-
Europe Artificial Lung Market by Application Type
-
Respiratory Failure
-
Lung Transplantation
-
Cardiac Support
-
-
Europe Artificial Lung Market by End Use Type
-
Hospitals
-
Home Care
-
Specialized Clinics
-
-
Europe Artificial Lung Market by Product Configuration Type
-
Portable Systems
-
Stationary Systems
-
Wearable Systems
-
-
Europe Artificial Lung Market by Regional Type
-
Germany
-
UK
-
France
-
Russia
-
Italy
-
Spain
-
Rest of Europe
-
-
GERMANY Outlook (USD Billion, 2019-2032)
-
GERMANY Artificial Lung Market by Type
-
Extracorporeal Membrane Oxygenation
-
Ventilator Support Systems
-
Implantable Artificial Lungs
-
-
GERMANY Artificial Lung Market by Application Type
-
Respiratory Failure
-
Lung Transplantation
-
Cardiac Support
-
-
GERMANY Artificial Lung Market by End Use Type
-
Hospitals
-
Home Care
-
Specialized Clinics
-
-
GERMANY Artificial Lung Market by Product Configuration Type
-
Portable Systems
-
Stationary Systems
-
Wearable Systems
-
-
UK Outlook (USD Billion, 2019-2032)
-
UK Artificial Lung Market by Type
-
Extracorporeal Membrane Oxygenation
-
Ventilator Support Systems
-
Implantable Artificial Lungs
-
-
UK Artificial Lung Market by Application Type
-
Respiratory Failure
-
Lung Transplantation
-
Cardiac Support
-
-
UK Artificial Lung Market by End Use Type
-
Hospitals
-
Home Care
-
Specialized Clinics
-
-
UK Artificial Lung Market by Product Configuration Type
-
Portable Systems
-
Stationary Systems
-
Wearable Systems
-
-
FRANCE Outlook (USD Billion, 2019-2032)
-
FRANCE Artificial Lung Market by Type
-
Extracorporeal Membrane Oxygenation
-
Ventilator Support Systems
-
Implantable Artificial Lungs
-
-
FRANCE Artificial Lung Market by Application Type
-
Respiratory Failure
-
Lung Transplantation
-
Cardiac Support
-
-
FRANCE Artificial Lung Market by End Use Type
-
Hospitals
-
Home Care
-
Specialized Clinics
-
-
FRANCE Artificial Lung Market by Product Configuration Type
-
Portable Systems
-
Stationary Systems
-
Wearable Systems
-
-
RUSSIA Outlook (USD Billion, 2019-2032)
-
RUSSIA Artificial Lung Market by Type
-
Extracorporeal Membrane Oxygenation
-
Ventilator Support Systems
-
Implantable Artificial Lungs
-
-
RUSSIA Artificial Lung Market by Application Type
-
Respiratory Failure
-
Lung Transplantation
-
Cardiac Support
-
-
RUSSIA Artificial Lung Market by End Use Type
-
Hospitals
-
Home Care
-
Specialized Clinics
-
-
RUSSIA Artificial Lung Market by Product Configuration Type
-
Portable Systems
-
Stationary Systems
-
Wearable Systems
-
-
ITALY Outlook (USD Billion, 2019-2032)
-
ITALY Artificial Lung Market by Type
-
Extracorporeal Membrane Oxygenation
-
Ventilator Support Systems
-
Implantable Artificial Lungs
-
-
ITALY Artificial Lung Market by Application Type
-
Respiratory Failure
-
Lung Transplantation
-
Cardiac Support
-
-
ITALY Artificial Lung Market by End Use Type
-
Hospitals
-
Home Care
-
Specialized Clinics
-
-
ITALY Artificial Lung Market by Product Configuration Type
-
Portable Systems
-
Stationary Systems
-
Wearable Systems
-
-
SPAIN Outlook (USD Billion, 2019-2032)
-
SPAIN Artificial Lung Market by Type
-
Extracorporeal Membrane Oxygenation
-
Ventilator Support Systems
-
Implantable Artificial Lungs
-
-
SPAIN Artificial Lung Market by Application Type
-
Respiratory Failure
-
Lung Transplantation
-
Cardiac Support
-
-
SPAIN Artificial Lung Market by End Use Type
-
Hospitals
-
Home Care
-
Specialized Clinics
-
-
SPAIN Artificial Lung Market by Product Configuration Type
-
Portable Systems
-
Stationary Systems
-
Wearable Systems
-
-
REST OF EUROPE Outlook (USD Billion, 2019-2032)
-
REST OF EUROPE Artificial Lung Market by Type
-
Extracorporeal Membrane Oxygenation
-
Ventilator Support Systems
-
Implantable Artificial Lungs
-
-
REST OF EUROPE Artificial Lung Market by Application Type
-
Respiratory Failure
-
Lung Transplantation
-
Cardiac Support
-
-
REST OF EUROPE Artificial Lung Market by End Use Type
-
Hospitals
-
Home Care
-
Specialized Clinics
-
-
REST OF EUROPE Artificial Lung Market by Product Configuration Type
-
Portable Systems
-
Stationary Systems
-
Wearable Systems
-
-
-
APAC Outlook (USD Billion, 2019-2032)
-
APAC Artificial Lung Market by Type
-
Extracorporeal Membrane Oxygenation
-
Ventilator Support Systems
-
Implantable Artificial Lungs
-
-
APAC Artificial Lung Market by Application Type
-
Respiratory Failure
-
Lung Transplantation
-
Cardiac Support
-
-
APAC Artificial Lung Market by End Use Type
-
Hospitals
-
Home Care
-
Specialized Clinics
-
-
APAC Artificial Lung Market by Product Configuration Type
-
Portable Systems
-
Stationary Systems
-
Wearable Systems
-
-
APAC Artificial Lung Market by Regional Type
-
China
-
India
-
Japan
-
South Korea
-
Malaysia
-
Thailand
-
Indonesia
-
Rest of APAC
-
-
CHINA Outlook (USD Billion, 2019-2032)
-
CHINA Artificial Lung Market by Type
-
Extracorporeal Membrane Oxygenation
-
Ventilator Support Systems
-
Implantable Artificial Lungs
-
-
CHINA Artificial Lung Market by Application Type
-
Respiratory Failure
-
Lung Transplantation
-
Cardiac Support
-
-
CHINA Artificial Lung Market by End Use Type
-
Hospitals
-
Home Care
-
Specialized Clinics
-
-
CHINA Artificial Lung Market by Product Configuration Type
-
Portable Systems
-
Stationary Systems
-
Wearable Systems
-
-
INDIA Outlook (USD Billion, 2019-2032)
-
INDIA Artificial Lung Market by Type
-
Extracorporeal Membrane Oxygenation
-
Ventilator Support Systems
-
Implantable Artificial Lungs
-
-
INDIA Artificial Lung Market by Application Type
-
Respiratory Failure
-
Lung Transplantation
-
Cardiac Support
-
-
INDIA Artificial Lung Market by End Use Type
-
Hospitals
-
Home Care
-
Specialized Clinics
-
-
INDIA Artificial Lung Market by Product Configuration Type
-
Portable Systems
-
Stationary Systems
-
Wearable Systems
-
-
JAPAN Outlook (USD Billion, 2019-2032)
-
JAPAN Artificial Lung Market by Type
-
Extracorporeal Membrane Oxygenation
-
Ventilator Support Systems
-
Implantable Artificial Lungs
-
-
JAPAN Artificial Lung Market by Application Type
-
Respiratory Failure
-
Lung Transplantation
-
Cardiac Support
-
-
JAPAN Artificial Lung Market by End Use Type
-
Hospitals
-
Home Care
-
Specialized Clinics
-
-
JAPAN Artificial Lung Market by Product Configuration Type
-
Portable Systems
-
Stationary Systems
-
Wearable Systems
-
-
SOUTH KOREA Outlook (USD Billion, 2019-2032)
-
SOUTH KOREA Artificial Lung Market by Type
-
Extracorporeal Membrane Oxygenation
-
Ventilator Support Systems
-
Implantable Artificial Lungs
-
-
SOUTH KOREA Artificial Lung Market by Application Type
-
Respiratory Failure
-
Lung Transplantation
-
Cardiac Support
-
-
SOUTH KOREA Artificial Lung Market by End Use Type
-
Hospitals
-
Home Care
-
Specialized Clinics
-
-
SOUTH KOREA Artificial Lung Market by Product Configuration Type
-
Portable Systems
-
Stationary Systems
-
Wearable Systems
-
-
MALAYSIA Outlook (USD Billion, 2019-2032)
-
MALAYSIA Artificial Lung Market by Type
-
Extracorporeal Membrane Oxygenation
-
Ventilator Support Systems
-
Implantable Artificial Lungs
-
-
MALAYSIA Artificial Lung Market by Application Type
-
Respiratory Failure
-
Lung Transplantation
-
Cardiac Support
-
-
MALAYSIA Artificial Lung Market by End Use Type
-
Hospitals
-
Home Care
-
Specialized Clinics
-
-
MALAYSIA Artificial Lung Market by Product Configuration Type
-
Portable Systems
-
Stationary Systems
-
Wearable Systems
-
-
THAILAND Outlook (USD Billion, 2019-2032)
-
THAILAND Artificial Lung Market by Type
-
Extracorporeal Membrane Oxygenation
-
Ventilator Support Systems
-
Implantable Artificial Lungs
-
-
THAILAND Artificial Lung Market by Application Type
-
Respiratory Failure
-
Lung Transplantation
-
Cardiac Support
-
-
THAILAND Artificial Lung Market by End Use Type
-
Hospitals
-
Home Care
-
Specialized Clinics
-
-
THAILAND Artificial Lung Market by Product Configuration Type
-
Portable Systems
-
Stationary Systems
-
Wearable Systems
-
-
INDONESIA Outlook (USD Billion, 2019-2032)
-
INDONESIA Artificial Lung Market by Type
-
Extracorporeal Membrane Oxygenation
-
Ventilator Support Systems
-
Implantable Artificial Lungs
-
-
INDONESIA Artificial Lung Market by Application Type
-
Respiratory Failure
-
Lung Transplantation
-
Cardiac Support
-
-
INDONESIA Artificial Lung Market by End Use Type
-
Hospitals
-
Home Care
-
Specialized Clinics
-
-
INDONESIA Artificial Lung Market by Product Configuration Type
-
Portable Systems
-
Stationary Systems
-
Wearable Systems
-
-
REST OF APAC Outlook (USD Billion, 2019-2032)
-
REST OF APAC Artificial Lung Market by Type
-
Extracorporeal Membrane Oxygenation
-
Ventilator Support Systems
-
Implantable Artificial Lungs
-
-
REST OF APAC Artificial Lung Market by Application Type
-
Respiratory Failure
-
Lung Transplantation
-
Cardiac Support
-
-
REST OF APAC Artificial Lung Market by End Use Type
-
Hospitals
-
Home Care
-
Specialized Clinics
-
-
REST OF APAC Artificial Lung Market by Product Configuration Type
-
Portable Systems
-
Stationary Systems
-
Wearable Systems
-
-
-
South America Outlook (USD Billion, 2019-2032)
-
South America Artificial Lung Market by Type
-
Extracorporeal Membrane Oxygenation
-
Ventilator Support Systems
-
Implantable Artificial Lungs
-
-
South America Artificial Lung Market by Application Type
-
Respiratory Failure
-
Lung Transplantation
-
Cardiac Support
-
-
South America Artificial Lung Market by End Use Type
-
Hospitals
-
Home Care
-
Specialized Clinics
-
-
South America Artificial Lung Market by Product Configuration Type
-
Portable Systems
-
Stationary Systems
-
Wearable Systems
-
-
South America Artificial Lung Market by Regional Type
-
Brazil
-
Mexico
-
Argentina
-
Rest of South America
-
-
BRAZIL Outlook (USD Billion, 2019-2032)
-
BRAZIL Artificial Lung Market by Type
-
Extracorporeal Membrane Oxygenation
-
Ventilator Support Systems
-
Implantable Artificial Lungs
-
-
BRAZIL Artificial Lung Market by Application Type
-
Respiratory Failure
-
Lung Transplantation
-
Cardiac Support
-
-
BRAZIL Artificial Lung Market by End Use Type
-
Hospitals
-
Home Care
-
Specialized Clinics
-
-
BRAZIL Artificial Lung Market by Product Configuration Type
-
Portable Systems
-
Stationary Systems
-
Wearable Systems
-
-
MEXICO Outlook (USD Billion, 2019-2032)
-
MEXICO Artificial Lung Market by Type
-
Extracorporeal Membrane Oxygenation
-
Ventilator Support Systems
-
Implantable Artificial Lungs
-
-
MEXICO Artificial Lung Market by Application Type
-
Respiratory Failure
-
Lung Transplantation
-
Cardiac Support
-
-
MEXICO Artificial Lung Market by End Use Type
-
Hospitals
-
Home Care
-
Specialized Clinics
-
-
MEXICO Artificial Lung Market by Product Configuration Type
-
Portable Systems
-
Stationary Systems
-
Wearable Systems
-
-
ARGENTINA Outlook (USD Billion, 2019-2032)
-
ARGENTINA Artificial Lung Market by Type
-
Extracorporeal Membrane Oxygenation
-
Ventilator Support Systems
-
Implantable Artificial Lungs
-
-
ARGENTINA Artificial Lung Market by Application Type
-
Respiratory Failure
-
Lung Transplantation
-
Cardiac Support
-
-
ARGENTINA Artificial Lung Market by End Use Type
-
Hospitals
-
Home Care
-
Specialized Clinics
-
-
ARGENTINA Artificial Lung Market by Product Configuration Type
-
Portable Systems
-
Stationary Systems
-
Wearable Systems
-
-
REST OF SOUTH AMERICA Outlook (USD Billion, 2019-2032)
-
REST OF SOUTH AMERICA Artificial Lung Market by Type
-
Extracorporeal Membrane Oxygenation
-
Ventilator Support Systems
-
Implantable Artificial Lungs
-
-
REST OF SOUTH AMERICA Artificial Lung Market by Application Type
-
Respiratory Failure
-
Lung Transplantation
-
Cardiac Support
-
-
REST OF SOUTH AMERICA Artificial Lung Market by End Use Type
-
Hospitals
-
Home Care
-
Specialized Clinics
-
-
REST OF SOUTH AMERICA Artificial Lung Market by Product Configuration Type
-
Portable Systems
-
Stationary Systems
-
Wearable Systems
-
-
-
MEA Outlook (USD Billion, 2019-2032)
-
MEA Artificial Lung Market by Type
-
Extracorporeal Membrane Oxygenation
-
Ventilator Support Systems
-
Implantable Artificial Lungs
-
-
MEA Artificial Lung Market by Application Type
-
Respiratory Failure
-
Lung Transplantation
-
Cardiac Support
-
-
MEA Artificial Lung Market by End Use Type
-
Hospitals
-
Home Care
-
Specialized Clinics
-
-
MEA Artificial Lung Market by Product Configuration Type
-
Portable Systems
-
Stationary Systems
-
Wearable Systems
-
-
MEA Artificial Lung Market by Regional Type
-
GCC Countries
-
South Africa
-
Rest of MEA
-
-
GCC COUNTRIES Outlook (USD Billion, 2019-2032)
-
GCC COUNTRIES Artificial Lung Market by Type
-
Extracorporeal Membrane Oxygenation
-
Ventilator Support Systems
-
Implantable Artificial Lungs
-
-
GCC COUNTRIES Artificial Lung Market by Application Type
-
Respiratory Failure
-
Lung Transplantation
-
Cardiac Support
-
-
GCC COUNTRIES Artificial Lung Market by End Use Type
-
Hospitals
-
Home Care
-
Specialized Clinics
-
-
GCC COUNTRIES Artificial Lung Market by Product Configuration Type
-
Portable Systems
-
Stationary Systems
-
Wearable Systems
-
-
SOUTH AFRICA Outlook (USD Billion, 2019-2032)
-
SOUTH AFRICA Artificial Lung Market by Type
-
Extracorporeal Membrane Oxygenation
-
Ventilator Support Systems
-
Implantable Artificial Lungs
-
-
SOUTH AFRICA Artificial Lung Market by Application Type
-
Respiratory Failure
-
Lung Transplantation
-
Cardiac Support
-
-
SOUTH AFRICA Artificial Lung Market by End Use Type
-
Hospitals
-
Home Care
-
Specialized Clinics
-
-
SOUTH AFRICA Artificial Lung Market by Product Configuration Type
-
Portable Systems
-
Stationary Systems
-
Wearable Systems
-
-
REST OF MEA Outlook (USD Billion, 2019-2032)
-
REST OF MEA Artificial Lung Market by Type
-
Extracorporeal Membrane Oxygenation
-
Ventilator Support Systems
-
Implantable Artificial Lungs
-
-
REST OF MEA Artificial Lung Market by Application Type
-
Respiratory Failure
-
Lung Transplantation
-
Cardiac Support
-
-
REST OF MEA Artificial Lung Market by End Use Type
-
Hospitals
-
Home Care
-
Specialized Clinics
-
-
REST OF MEA Artificial Lung Market by Product Configuration Type
-
Portable Systems
-
Stationary Systems
-
Wearable Systems
-
-
Leave a Comment